TICKERNERD
Menu
VSEEVSEEHealthcare · Health Information Services

VSEE Stock Forecast: VSee Health, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$0.09
+11.39% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 1 Aug 2026 — in the lower half.

Market cap
$4.4M
Ticker Nerd rank
31 / 100
Median analyst target
—
Analysts covering
1
Total return, dividends reinvested
1W
+12.8%
1M
−20.0%
YTD
−76.5%
1Y
−92.7%
From 52W high
−93.7%
From 52W low
+22.2%
$0.07
$1.39
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

VSEE stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores VSee Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
96
Accruals
91
Growth
59
Issuance
59
Volatility
30
Revisions
25
Quality
21
Value
15
Momentum
6

Size (96): Smaller than most of the companies we track.

Momentum (6): The shares have been drifting down relative to others.

The rank is the raw material. Whether the rules would actually own VSee Health, Inc. — and when they’d sell — is the membership.

Wall Street

VSEE stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on VSEE, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$0.50$1.00$1.50Oct 25Jan 26Apr 26Jul 26VSEE

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Recent analyst actionsNewest first
DateFirmActionRatingTarget
24 Feb 2025Maxim GroupInitiatesBuy$5.00
24 Feb 2025Maxim GroupInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

VSEE analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

VSee Health, Inc. (VSEE) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.5×

Cheaper than 71% of US stocks

Price / sales
0.3×

Cheaper than 88% of US stocks

Price / book
0.7×

Cheaper than 81% of US stocks

EV / EBITDA
−0.6×

Cheaper than 65% of US stocks

Growth & margins
Revenue growth (YoY)
−4.9%

Higher than 21% of US stocks

Earnings growth (YoY)
−18.1%

Higher than 20% of US stocks

Gross margin
37.9%

Higher than 49% of US stocks

Operating margin
−94.1%

Higher than 14% of US stocks

Net margin
−92.4%

Higher than 6% of US stocks

Returns & dividend
Return on equity
−945.7%

Higher than 1% of US stocks

Return on assets
−34.9%

Higher than 12% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

VSEE vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
VSEEVSee Health, Inc.$4.4M
31
ACONAclarion, Inc.$5.5M
23
MNDRMobile-health Network Solutions$2.2M
14
HCTIHealthcare Triangle, Inc.$2.2M
20
MGRXMangoceuticals, Inc.$9.6M
25
BFRGBullFrog AI Holdings, Inc.$10.2M
29
ZCMDZhongchao, Inc.$1.3M
22
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. VSEE appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest VSEE news & analysis

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings

Accesswire · 30 July 2026positive

VSee Health, Inc. has entered into a non-binding letter of intent to acquire healthcare technology and operating assets that support an integrated healthcare commerce platform serving the U.S. clinic-based wellness market, in a deal valued at $42 million that would add over $35 million in annualized revenue and more than $7 million in earnings.

Why it matters — The acquisition would significantly boost VSee's revenue and earnings without initial shareholder dilution, expanding its capabilities in the clinic-based wellness market.

VSEE Vertically Integrated Healthcare Commerce Platform

Accesswire · 29 July 2026positive

VSee Health, Inc. announced it has entered a non-binding letter of intent to acquire healthcare technology and operating assets that support an integrated healthcare commerce platform for the U.S. clinic-based wellness market.

Why it matters — VSEE watchers would care because the proposed acquisition could significantly expand the company's revenue and earnings if completed.

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value

Accesswire · 28 July 2026positive

VSee Health's Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value, stating the company has reached an important inflection point.

Why it matters — A strategic review often signals potential major corporate changes such as mergers, acquisitions, or restructuring, which could significantly impact the company's future direction and shareholder value.

FAQ

Frequently asked questions about VSEE stock

Is VSEE stock a buy right now?

Of the 1 analysts covering VSee Health, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks VSee Health, Inc. 31 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank VSEE?

As at 1 Aug 2026, VSee Health, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (96 of 100).

What is the VSEE stock forecast for 2030?

No analyst covering VSee Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VSEE are extrapolating price history, which says nothing about the business.

How has VSEE stock performed over the past year?

VSee Health, Inc. returned -92.7% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does VSee Health, Inc. do?

Vsee Health Inc. is a technology-centric company specializing in telemedicine solutions.

What is the latest news on VSEE?

The most recent item we track (Accesswire, 30 July 2026): "VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings". VSee Health, Inc. has entered into a non-binding letter of intent to acquire healthcare technology and operating assets that support an integrated healthcare commerce platform serving the U.S. clinic-based wellness market, in a deal valued at $42 million that would add over $35 million in annualized revenue and more than $7 million in earnings.

Company

About VSee Health, Inc.

Vsee Health Inc. is a technology-centric company specializing in telemedicine solutions. Its primary objective is to revolutionize the healthcare delivery system by providing a comprehensive platform that integrates video conferencing, secure messaging, file sharing, and mobile health monitoring. This platform is designed to facilitate remote consultations and patient engagement, significantly impacting sectors such as healthcare, technology, and communication services. By offering solutions that enable virtual office visits and remote patient management, Vsee Health Inc. plays a crucial role in enhancing access to healthcare, especially in underserved regions. It collaborates with a wide range of healthcare providers, medical institutions, and government agencies, highlighting its market importance in catalyzing the shift towards digital health. As the healthcare landscape continues to evolve towards more patient-centered and technology-driven models, Vsee Health Inc. remains at the forefront, offering innovations that bridge the gap between patients and healthcare professionals.

CEO Dr. Imoigele P. Aisiku M.B.A., M.D. · 209 employees · United States · https://www.vseehealth.com